SCHEMBL1403899

SCHEMBL1403899

CC(C)N(CCCCCO)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.35
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1404086 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL1403966 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL27696864 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL1404081 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL1619600 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL1403898 0.97 MEN1 (0.43) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL557434 0.89 MEN1 (0.46) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL21847385 0.85 MEN1 (0.32) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL21847357 0.85 MEN1 (0.32) MEN1KMT2AALDH1A1LMNATSHR
SCHEMBL21847376 0.85 MEN1 (0.32) MEN1KMT2AALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399409-B1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF SE (DE) 2012-10-31 EP claimed
CN-100349851-C Method for producing acrylic acid esters BASF AG (DE) 2007-11-21 CN claimed
US-7268251-B2 Method for producing (meth) acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2007-09-11 US claimed
US-7026503-B2 Method for producing (meth)acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2006-04-11 US claimed
EP-1399408-B1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF AG (DE) 2006-03-22 EP claimed
US-11696953-B2 Poly(beta-amino esters) and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-07-11 US disclosed
US-11696953-B2 Poly(beta-amino esters) and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-07-11 US disclosed
US-11041069-B2 Gene delivery carrier MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-22 US disclosed
US-20190194444-A1 GENE DELIVERY CARRIER POLITECNICO DI MILANO (IT) 2019-06-27 US disclosed
US-20190125874-A1 POLY (BETA-AMINO ESTERS) AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2019-05-02 US disclosed
US-10174349-B2 Recombinant cell producing 2-hydroxyisobutyric acid EVONIK ROEHM GMBH (DE) 2019-01-08 US disclosed
EP-2291530-B1 RECOMBINANT CELL PRODUCING 2-HYDROXYISOBUTYRIC ACID EVONIK ROEHM GMBH (DE) 2018-12-26 EP disclosed
WO-2008061819-A1 PROCESS FOR PREPARING (METH)ACRYLIC ACID EVONIK RÖHM GMBH (DE) 2008-05-29 WO disclosed
CN-1252276-C Lycopen production method VITATENE SA (ES) 2006-04-19 CN disclosed
CN-1353765-A Lycopen production method VITATENE SA (ES) 2002-06-12 CN disclosed
EP-0748310-B1 DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY ITALFARMACO SPA (IT) 1999-06-02 EP disclosed
US-5827881-A ADMINISTERING FOR TREATMENT OF VIRAL DISEASES OR AS ANTIINFLAMMATORY AGENTS ITALFARMACO S.P.A. (IT) 1998-10-27 US disclosed
EP-0748310-A1 DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY ITALFARMACO S.p.A. (IT) 1996-12-18 EP disclosed
WO-1995023128-A1 DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY ITALFARMACO S.P.A. (IT) 1995-08-31 WO disclosed
EP-0289262-A2 Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1988-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194444-A1 GENE DELIVERY CARRIER PAICS, PBDC1, BCAT1 MEN1 3571/4885KMT2A 2017/4885ALDH1A1 2765/4885
US-20190125874-A1 POLY (BETA-AMINO ESTERS) AND USES THEREOF BCAT1, BCAT2, SNRPE MEN1 4493/4885KMT2A 2481/4885ALDH1A1 4132/4885
US-11041069-B2 Gene delivery carrier PAICS, PBDC1, BCAT1 MEN1 3571/4885KMT2A 2017/4885ALDH1A1 2765/4885
US-11696953-B2 Poly(beta-amino esters) and uses thereof BCAT1, BCAT2, SNRPE MEN1 4493/4885KMT2A 2481/4885ALDH1A1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.